• About
  • Information
  • Company
  • Location
  • Board of Directors
  • Affiliates
  • Partner
Japanese
CRECON genomics

Improving
Health Through
Genomics

About

contributing in the fields of cancer prevention, early detection, and treatment, as well as working to advance the selection of therapeutic drugs based on individual genomic data and the latest in domestic and international research.

The importance and social significance of cancer prevention is increasing worldwide. In accordance with our company’s vision to deliver more accurate and faster technologies which can reach more people: In cooperation with domestic and international research institutes, medical institutions, and our partner companies, we aim to deliver the latest in diagnostic technologies.

Utilizing the latest
in preventive medicine
and DNA analysis technologies,
we aim to establish and popularize
new diagnostic methods.

News

TOPTOPNewsPresentation on the use of cfDNA as a health marker and building of a cfDNA knowledge base at the AMIA (American Medical Informatics Association) 2024 Annual Symposium in San Francisco, California, USA
2024/11/11

Presentation on the use of cfDNA as a health marker and building of a cfDNA knowledge base at the AMIA (American Medical Informatics Association) 2024 Annual Symposium in San Francisco, California, USA

  • Previous
Return to List
CRECON genomics ©2023 CRECON GENOMICS INC. All Rights Reserved.